Drug Profile
SR 3775
Alternative Names: Ganciclovir cyclic phosphonateLatest Information Update: 10 Sep 1998
Price :
$50
*
At a glance
- Originator SRI International
- Class Antivirals; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cytomegalovirus infections
Most Recent Events
- 10 Sep 1998 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)
- 26 Aug 1996 New profile
- 26 Aug 1996 Preclinical development for Cytomegalovirus infections in USA (Unknown route)